ABBV vs COR · P/E 81, rev $61.16B vs P/E 21, rev $321.33B
AbbVie Inc (ABBV) versus Cencora Inc. (COR) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Not investment advice. Open the ABBV and COR stock pages for the full models.
Not investment advice.